Study of Tolerant Kidney Transplant Recipients (FACTOR)

Principal Investigator

Kenneth Newell | Emory University | Atlanta, GA

Locations

Throughout North America

Study Code

ITN507ST

Study Status

Completed

Abstract

The objectives of this study are: (1) to identify patients who are functionally tolerant following kidney transplantation as well as relevant groups for comparison, (2) to enter demographic and clinical data from these patients into an electronic database thereby creating a registry of tolerant kidney transplant recipients in order to facilitate subsequent mechanistic studies, and (3) to use cutting edge research technologies to define surrogate markers of tolerance and gain new insights into immune mechanisms underlying tolerance induction in humans. The study initially was designed to compare eight immunologically distinct groups of kidney transplant recipients: tolerant group, acceptors, graft loss group, monotherapy group, standard immunotherapy group, identical twins, living donors and chronic rejectors. Due to the success of recruiting participants and the analysis of biological samples collected to date, the ongoing study is limited to the enrollment of individuals in the tolerant and monotherapy groups as well as their living donors. Comparison of the tolerant group, the standard immunotherapy group, and a group of healthy volunteers using microarrays, RT-PCR, and flow phenotyping has revealed a set of candidate genes and cell phenotypes that may be associated with tolerance.  These assays have been performed under the direction of the ITN's Tolerance Assay and Data Analysis Group. The ITN Clinical Specimen Repository Core Facility will process and bank all clinical specimens obtained for this study, with the hope that it will become a valuable resource open to the community for additional future studies of this rare cohort.

Notice: This special project of the ITN will create a world-wide registry of tolerant kidney transplant recipients to act as a resource for identifying new biological markers of kidney transplant tolerance. To initiate the effort, investigators who are aware of such patients are asked to contact Dr. Ken Newell at 404.727.2489 or kanewell@emory.edu.

Qualification

Articles

DOI: 

http://dx.doi.org/10.1111/ajt.13480

,‎ 

PMID: 

26461968

,‎ 

PMCID: 

PMC4725587

,‎ 

PubMed

,‎ 

Reprint

DOI: 

http://dx.doi.org/10.1172/JCI39933

,‎ 

PMID: 

20501946

,‎ 

PMCID: 

PMC2877933

,‎ 

PubMed

,‎ 

Reprint

DOI: 

http://dx.doi.org/10.1016/j.humimm.2018.02.007

,‎ 

PMID: 

29448053

,‎ 

PMCID: 

PMC5924709

,‎ 

PubMed

,‎ 

Reprint